speb/financial-data huggingface dataset:
DRCT balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1243000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 4542000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 41000.00
DRCT income_statement (quarterly, 2025-06-30) — Other Gand A: 2348000.00
DRCT income_statement (quarterly, 2025-06-30) — Other Income Expense: 19000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 8753000.00
DRCT cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1082000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 298000.00
DRCT income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 19000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Other Properties: 794000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Payables: 6498000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 8058000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 256000.00
DRCT income_statement (quarterly, 2025-06-30) — Pretax Income: -4196000.00
DRCT cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
DRCT balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
DRCT cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 0.00
DRCT balance_sheet (quarterly, 2025-06-30) — Receivables: 3891000.00
DRCT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 6583000.00
DRCT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 610000.00
DRCT cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
DRCT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -13378000.00
DRCT income_statement (quarterly, 2025-06-30) — Salaries And Wages: 3639000.00
DRCT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 5987000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Share Issued: 54860.00
DRCT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 389000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -10580000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -25853000.00
DRCT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
DRCT income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
DRCT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
DRCT balance_sheet (quarterly, 2025-06-30) — Total Assets: 23326000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 22930000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Total Debt: 38982000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -24581000.00
DRCT income_statement (quarterly, 2025-06-30) — Total Expenses: 12570000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 47907000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 16599000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 34232000.00
DRCT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -2426000.00
DRCT income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 588000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 41000.00
DRCT balance_sheet (quarterly, 2025-06-30) — Working Capital: -6948000.00
DRCT income_statement (quarterly, 2025-09-30) — +Operating Expense: 6125000.00
DRCT income_statement (quarterly, 2025-09-30) — +Total Revenue: 7984000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 8183000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3594000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -777000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 14862000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -944000.00
DRCT cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 488000.00
DRCT cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 488000.00
DRCT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 58486.00
DRCT income_statement (quarterly, 2025-09-30) — Basic EPS: -52.80
DRCT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1593000.00
DRCT cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: 0.00
DRCT balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 881000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 27000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 871000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 871000.00
DRCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 916000.00
DRCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 0.00
DRCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1638000.00
DRCT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 2130000.00
DRCT cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 16000.00
DRCT cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 25000.00
DRCT cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -50000.00
DRCT cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -22000.00
DRCT cash_flow (quarterly, 2025-09-30) — Change In Payable: 2155000.00
DRCT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2171000.00
DRCT cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -36000.00
DRCT cash_flow (quarterly, 2025-09-30) — Change In Receivables: 291000.00
DRCT cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 25000.00
DRCT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 2354000.00
DRCT cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 291000.00
DRCT cash_flow (quarterly, 2025-09-30) — Changes In Cash: -722000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Common Stock: 27000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -1169000.00
DRCT cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 766000.00
DRCT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 5770000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 3477000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Current Assets: 6603000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 215000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Current Debt: 4931000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 5146000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 548000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 548000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 17747000.00
DRCT cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 0.00
DRCT cash_flow (quarterly, 2025-09-30) — Deferred Tax: 0.00
DRCT cash_flow (quarterly, 2025-09-30) — Depreciation: 115000.00
DRCT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 603000.00
DRCT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 603000.00
DRCT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 58486.00
DRCT income_statement (quarterly, 2025-09-30) — Diluted EPS: -52.80
DRCT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2680000.00
DRCT income_statement (quarterly, 2025-09-30) — EBIT: -4145000.00
DRCT income_statement (quarterly, 2025-09-30) — EBITDA: -3542000.00
DRCT cash_flow (quarterly, 2025-09-30) — End Cash Position: 871000.00
DRCT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 916000.00
DRCT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -1638000.00
DRCT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 6125000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Goodwill: 6520000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 14785000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 4538000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1690000.00
DRCT income_statement (quarterly, 2025-09-30) — Gross Profit: 2214000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 66000.00
DRCT income_statement (quarterly, 2025-09-30) — Interest Expense: 855000.00
DRCT income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 855000.00
DRCT income_statement (quarterly, 2025-09-30) — Interest Income: 450000.00
DRCT income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 450000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Interest Payable: 0.00
DRCT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 14579000.00
DRCT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
DRCT cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 766000.00
DRCT cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 3804000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Leases: 66000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 666000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 10817000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 11483000.00
DRCT cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 3804000.00
DRCT cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -3700000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 875000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Minority Interest: -5526000.00
DRCT income_statement (quarterly, 2025-09-30) — Minority Interests: 2320000.00
DRCT cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 766000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Net Debt: 14877000.00
DRCT income_statement (quarterly, 2025-09-30) — Net Income: -2680000.00
DRCT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2680000.00
DRCT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -5000000.00
DRCT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2680000.00
DRCT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2680000.00
DRCT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -5000000.00
DRCT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -5000000.00
DRCT income_statement (quarterly, 2025-09-30) — Net Interest Income: -1104000.00
DRCT cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 104000.00
DRCT cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 104000.00
DRCT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1104000.00
DRCT cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 46000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Net PPE: 913000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -15954000.00
DRCT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -3542000.00
DRCT income_statement (quarterly, 2025-09-30) — Normalized Income: -2680000.00
DRCT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1638000.00
DRCT income_statement (quarterly, 2025-09-30) — Operating Income: -3911000.00
DRCT income_statement (quarterly, 2025-09-30) — Operating Revenue: 7984000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 75795.00
DRCT balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2138000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 4931000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 41000.00
DRCT income_statement (quarterly, 2025-09-30) — Other Gand A: 2501000.00
DRCT income_statement (quarterly, 2025-09-30) — Other Income Expense: 15000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 8265000.00
DRCT cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 25000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 234000.00
DRCT income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 15000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Other Properties: 749000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Payables: 8249000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 11726000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 286000.00
DRCT income_statement (quarterly, 2025-09-30) — Pretax Income: -5000000.00
DRCT cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
DRCT balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
DRCT cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 6000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Receivables: 3594000.00
DRCT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 5770000.00
DRCT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 603000.00
DRCT cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -3700000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -16058000.00
DRCT income_statement (quarterly, 2025-09-30) — Salaries And Wages: 3624000.00
DRCT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 6125000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Share Issued: 75795.00
DRCT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 374000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -1169000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -15954000.00
DRCT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
DRCT income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
DRCT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
DRCT balance_sheet (quarterly, 2025-09-30) — Total Assets: 22535000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 9648000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Total Debt: 16629000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -6695000.00
DRCT income_statement (quarterly, 2025-09-30) — Total Expenses: 11895000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 29230000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 15932000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 11483000.00
DRCT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -3911000.00
DRCT income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 699000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 66000.00
DRCT balance_sheet (quarterly, 2025-09-30) — Working Capital: -11144000.00
DRCT income_statement (annual, 2025-12-31) — +Operating Expense: 25174000.00
DRCT income_statement (quarterly, 2025-12-31) — +Operating Expense: 6745000.00
DRCT income_statement (annual, 2025-12-31) — +Total Revenue: 34694000.00
DRCT income_statement (quarterly, 2025-12-31) — +Total Revenue: 8408000.00
DRCT balance_sheet (annual, 2025-12-31) — Accounts Payable: 7820000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 7820000.00
DRCT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 3126000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 3126000.00
DRCT balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -824000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -824000.00
DRCT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 25811000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 25811000.00
DRCT balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -944000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -944000.00
DRCT cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 1879000.00
DRCT cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 414000.00
DRCT cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 1879000.00
DRCT cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 414000.00
DRCT income_statement (annual, 2025-12-31) — Basic Average Shares: 76999.00
DRCT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 172749.00
DRCT income_statement (annual, 2025-12-31) — Basic EPS: -303.16
DRCT income_statement (quarterly, 2025-12-31) — Basic EPS: -88.00
DRCT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1445000.00
DRCT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 871000.00
DRCT cash_flow (annual, 2025-12-31) — Capital Expenditure: -87000.00
DRCT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -49000.00
DRCT cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -87000.00
DRCT cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -49000.00
DRCT balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 829000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 829000.00
DRCT balance_sheet (annual, 2025-12-31) — Capital Stock: 1000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1000.00
DRCT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 728000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 728000.00
DRCT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 728000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 728000.00
DRCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 8277000.00
DRCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1777000.00
DRCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -87000.00
DRCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -49000.00
DRCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -8907000.00
DRCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1871000.00
DRCT cash_flow (annual, 2025-12-31) — Change In Account Payable: 911000.00
DRCT cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 272000.00
DRCT cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 638000.00
DRCT cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -340000.00
DRCT cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -65000.00
DRCT cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: -131000.00
DRCT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -193000.00
DRCT cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -51000.00
DRCT cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 6000.00
DRCT cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -35000.00
DRCT cash_flow (annual, 2025-12-31) — Change In Payable: 846000.00
DRCT cash_flow (quarterly, 2025-12-31) — Change In Payable: 141000.00
DRCT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 1484000.00
DRCT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -199000.00
DRCT cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -27000.00
DRCT cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 851000.00
DRCT cash_flow (annual, 2025-12-31) — Change In Receivables: 1841000.00
DRCT cash_flow (quarterly, 2025-12-31) — Change In Receivables: 468000.00
DRCT cash_flow (annual, 2025-12-31) — Change In Tax Payable: -65000.00
DRCT cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: -131000.00
DRCT cash_flow (annual, 2025-12-31) — Change In Working Capital: 3111000.00
DRCT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1034000.00
DRCT cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 1841000.00
DRCT cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 468000.00
DRCT cash_flow (annual, 2025-12-31) — Changes In Cash: -717000.00
DRCT cash_flow (quarterly, 2025-12-31) — Changes In Cash: -143000.00
DRCT balance_sheet (annual, 2025-12-31) — Common Stock: 1000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Common Stock: 1000.00
DRCT balance_sheet (annual, 2025-12-31) — Common Stock Equity: -1908000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -1908000.00
DRCT cash_flow (annual, 2025-12-31) — Common Stock Issuance: 8688000.00
DRCT cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1980000.00
DRCT income_statement (annual, 2025-12-31) — Cost Of Revenue: 24275000.00
DRCT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 6158000.00
DRCT balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 5366000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 5366000.00
DRCT balance_sheet (annual, 2025-12-31) — Current Assets: 4744000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Current Assets: 4744000.00
DRCT balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 221000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 221000.00
DRCT balance_sheet (annual, 2025-12-31) — Current Debt: 12003000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Current Debt: 12003000.00
DRCT balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 12224000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 12224000.00
DRCT balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 513000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 513000.00
DRCT balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 513000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 513000.00
DRCT balance_sheet (annual, 2025-12-31) — Current Liabilities: 26425000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 26425000.00
DRCT cash_flow (annual, 2025-12-31) — Deferred Income Tax: 0.00
DRCT cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 0.00
DRCT cash_flow (annual, 2025-12-31) — Deferred Tax: 0.00
DRCT cash_flow (quarterly, 2025-12-31) — Deferred Tax: 0.00
DRCT cash_flow (annual, 2025-12-31) — Depreciation: 444000.00
DRCT cash_flow (quarterly, 2025-12-31) — Depreciation: 94000.00
DRCT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2323000.00
DRCT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 508000.00
DRCT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2323000.00
DRCT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 508000.00
DRCT income_statement (annual, 2025-12-31) — Diluted Average Shares: 76999.00
DRCT income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 172749.00
DRCT income_statement (annual, 2025-12-31) — Diluted EPS: -303.16
DRCT income_statement (quarterly, 2025-12-31) — Diluted EPS: -88.00
DRCT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -23357000.00
DRCT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -16073000.00
DRCT income_statement (annual, 2025-12-31) — EBIT: -22520000.00
DRCT income_statement (quarterly, 2025-12-31) — EBIT: -10645000.00
DRCT income_statement (annual, 2025-12-31) — EBITDA: -20197000.00
DRCT income_statement (quarterly, 2025-12-31) — EBITDA: -10137000.00
DRCT cash_flow (annual, 2025-12-31) — End Cash Position: 728000.00
DRCT cash_flow (quarterly, 2025-12-31) — End Cash Position: 728000.00
DRCT cash_flow (annual, 2025-12-31) — Financing Cash Flow: 8277000.00
DRCT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 1777000.00
DRCT cash_flow (annual, 2025-12-31) — Free Cash Flow: -8994000.00
DRCT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -1920000.00
DRCT income_statement (annual, 2025-12-31) — General And Administrative Expense: 25174000.00
DRCT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 6745000.00
DRCT balance_sheet (annual, 2025-12-31) — Goodwill: 6520000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Goodwill: 6520000.00
DRCT balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 14372000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 14372000.00
DRCT balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 4070000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 4070000.00
DRCT balance_sheet (annual, 2025-12-31) — Gross PPE: 1692000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1692000.00
DRCT income_statement (annual, 2025-12-31) — Gross Profit: 10419000.00
DRCT income_statement (quarterly, 2025-12-31) — Gross Profit: 2250000.00
DRCT cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 3000.00
DRCT income_statement (annual, 2025-12-31) — Interest Expense: 5203000.00
DRCT income_statement (quarterly, 2025-12-31) — Interest Expense: 1942000.00
DRCT income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 5203000.00
DRCT income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1942000.00
DRCT cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 835000.00
DRCT balance_sheet (annual, 2025-12-31) — Interest Payable: 5000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Interest Payable: 5000.00
DRCT balance_sheet (annual, 2025-12-31) — Invested Capital: 10241000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 10241000.00
DRCT cash_flow (annual, 2025-12-31) — Investing Cash Flow: -87000.00
DRCT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -49000.00
DRCT cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 8688000.00
DRCT cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 1980000.00
DRCT cash_flow (annual, 2025-12-31) — Issuance Of Debt: 3804000.00
DRCT cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
DRCT balance_sheet (annual, 2025-12-31) — Leases: 66000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Leases: 66000.00
DRCT balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 608000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 608000.00
DRCT balance_sheet (annual, 2025-12-31) — Long Term Debt: 146000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 146000.00
DRCT balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 754000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 754000.00
DRCT cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 3804000.00
DRCT cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
DRCT cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -3700000.00
DRCT cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
DRCT balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 924000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 924000.00
DRCT balance_sheet (annual, 2025-12-31) — Minority Interest: -5115000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Minority Interest: -5115000.00
DRCT income_statement (annual, 2025-12-31) — Minority Interests: 8777000.00
DRCT income_statement (quarterly, 2025-12-31) — Minority Interests: 925000.00
DRCT cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 8688000.00
DRCT cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1980000.00
DRCT balance_sheet (annual, 2025-12-31) — Net Debt: 11421000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Net Debt: 11421000.00
DRCT income_statement (annual, 2025-12-31) — Net Income: -18946000.00
DRCT income_statement (quarterly, 2025-12-31) — Net Income: -11662000.00
DRCT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -23357000.00
DRCT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -16073000.00
DRCT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -27723000.00
DRCT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -12587000.00
DRCT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -18946000.00
DRCT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -11662000.00
DRCT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -18946000.00
DRCT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -11662000.00
DRCT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -27723000.00
DRCT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -12587000.00
DRCT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -27723000.00
DRCT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -12587000.00
DRCT income_statement (annual, 2025-12-31) — Net Interest Income: -5203000.00
DRCT income_statement (quarterly, 2025-12-31) — Net Interest Income: -464000.00
DRCT cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 104000.00
DRCT cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
DRCT cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 104000.00
DRCT cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
DRCT income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -5203000.00
DRCT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -464000.00
DRCT cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -515000.00
DRCT cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -203000.00
DRCT balance_sheet (annual, 2025-12-31) — Net PPE: 868000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Net PPE: 868000.00
DRCT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -16280000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -16280000.00
DRCT income_statement (annual, 2025-12-31) — Normalized EBITDA: -12553000.00
DRCT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -10137000.00
DRCT income_statement (annual, 2025-12-31) — Normalized Income: -11302000.00
DRCT income_statement (quarterly, 2025-12-31) — Normalized Income: -11662000.00
DRCT cash_flow (annual, 2025-12-31) — Operating Cash Flow: -8907000.00
DRCT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -1871000.00
DRCT cash_flow (annual, 2025-12-31) — Operating Gains Losses: 3769000.00
DRCT income_statement (annual, 2025-12-31) — Operating Income: -14755000.00
DRCT income_statement (quarterly, 2025-12-31) — Operating Income: -4495000.00
DRCT income_statement (annual, 2025-12-31) — Operating Revenue: 34694000.00
DRCT income_statement (quarterly, 2025-12-31) — Operating Revenue: 8408000.00
DRCT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 331076.00
DRCT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 331076.00
DRCT balance_sheet (annual, 2025-12-31) — Other Current Assets: 349000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 349000.00
DRCT balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 12003000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 12003000.00
DRCT balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 41000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 41000.00
DRCT income_statement (annual, 2025-12-31) — Other Gand A: 10662000.00
DRCT income_statement (quarterly, 2025-12-31) — Other Gand A: 3160000.00
DRCT income_statement (annual, 2025-12-31) — Other Income Expense: -7765000.00
DRCT income_statement (quarterly, 2025-12-31) — Other Income Expense: -7628000.00
DRCT balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 7852000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 7852000.00
DRCT cash_flow (annual, 2025-12-31) — Other Non Cash Items: 8137000.00
DRCT cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 5014000.00
DRCT balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 172000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 172000.00
DRCT income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -121000.00
DRCT income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 16000.00
DRCT balance_sheet (annual, 2025-12-31) — Other Properties: 702000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Other Properties: 702000.00
DRCT income_statement (annual, 2025-12-31) — Other Special Charges: 7644000.00
DRCT income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 4411000.00
DRCT balance_sheet (annual, 2025-12-31) — Payables: 7820000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Payables: 7820000.00
DRCT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 13186000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 13186000.00
DRCT balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 461000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 461000.00
DRCT balance_sheet (annual, 2025-12-31) — Prepaid Assets: 541000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 541000.00
DRCT income_statement (annual, 2025-12-31) — Pretax Income: -27723000.00
DRCT income_statement (quarterly, 2025-12-31) — Pretax Income: -12587000.00
DRCT cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
DRCT cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
DRCT balance_sheet (annual, 2025-12-31) — Properties: 0.00
DRCT balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
DRCT cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 6000.00
DRCT cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 0.00
DRCT balance_sheet (annual, 2025-12-31) — Receivables: 3126000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Receivables: 3126000.00
DRCT income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 24275000.00
DRCT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 6158000.00
DRCT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2323000.00
DRCT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 508000.00
DRCT cash_flow (annual, 2025-12-31) — Repayment Of Debt: -3700000.00
DRCT cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
DRCT balance_sheet (annual, 2025-12-31) — Retained Earnings: -27720000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -27720000.00
DRCT income_statement (annual, 2025-12-31) — Salaries And Wages: 14512000.00
DRCT income_statement (quarterly, 2025-12-31) — Salaries And Wages: 3585000.00
DRCT income_statement (annual, 2025-12-31) — Selling General And Administration: 25174000.00
DRCT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 6745000.00
DRCT balance_sheet (annual, 2025-12-31) — Share Issued: 331076.00
DRCT balance_sheet (quarterly, 2025-12-31) — Share Issued: 331076.00
DRCT income_statement (annual, 2025-12-31) — Special Income Charges: -7644000.00
DRCT cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1470000.00
DRCT cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 391000.00
DRCT balance_sheet (annual, 2025-12-31) — Stockholders Equity: -1908000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -1908000.00
DRCT balance_sheet (annual, 2025-12-31) — Tangible Book Value: -16280000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -16280000.00
DRCT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
DRCT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
DRCT income_statement (annual, 2025-12-31) — Tax Provision: 0.00
DRCT income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
DRCT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
DRCT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
DRCT balance_sheet (annual, 2025-12-31) — Total Assets: 20156000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Total Assets: 20156000.00
DRCT balance_sheet (annual, 2025-12-31) — Total Capitalization: -1762000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -1762000.00
DRCT balance_sheet (annual, 2025-12-31) — Total Debt: 12978000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Total Debt: 12978000.00
DRCT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -7023000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -7023000.00
DRCT income_statement (annual, 2025-12-31) — Total Expenses: 49449000.00
DRCT income_statement (quarterly, 2025-12-31) — Total Expenses: 12903000.00
DRCT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 27179000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 27179000.00
DRCT balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 15412000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 15412000.00
DRCT balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 754000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 754000.00
DRCT income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -14755000.00
DRCT income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -4495000.00
DRCT income_statement (annual, 2025-12-31) — Total Unusual Items: -7644000.00
DRCT income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -7644000.00
DRCT balance_sheet (annual, 2025-12-31) — Working Capital: -21681000.00
DRCT balance_sheet (quarterly, 2025-12-31) — Working Capital: -21681000.00
DRCT income_statement (quarterly, 2026-03-31) — +Operating Expense: 5513000.00
DRCT income_statement (quarterly, 2026-03-31) — +Total Revenue: 6680000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 8294000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2782000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -857000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 28403000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -944000.00
DRCT cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 414000.00
DRCT cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 414000.00
DRCT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 143750.00
DRCT income_statement (quarterly, 2026-03-31) — Basic EPS: -41.28
DRCT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 728000.00
DRCT cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: 0.00
DRCT balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 777000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 796000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 796000.00
DRCT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 1118000.00
DRCT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 0.00
DRCT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -1050000.00
DRCT cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 1114000.00
DRCT cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -275000.00
DRCT cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 0.00
DRCT cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -53000.00
DRCT cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 263000.00
DRCT cash_flow (quarterly, 2026-03-31) — Change In Payable: 1114000.00
DRCT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 839000.00
DRCT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 127000.00
DRCT cash_flow (quarterly, 2026-03-31) — Change In Receivables: 344000.00
DRCT cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 0.00
DRCT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 1520000.00
DRCT cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 344000.00
DRCT cash_flow (quarterly, 2026-03-31) — Changes In Cash: 68000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -4566000.00
DRCT cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 1119000.00
DRCT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 4418000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1523000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Current Assets: 4404000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 227000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Current Debt: 16548000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 16775000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 776000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 776000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 28285000.00
DRCT cash_flow (quarterly, 2026-03-31) — Depreciation: 80000.00
DRCT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 494000.00
DRCT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 494000.00
DRCT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 143750.00
DRCT income_statement (quarterly, 2026-03-31) — Diluted EPS: -41.28
DRCT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -5932000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 512000.00
DRCT income_statement (quarterly, 2026-03-31) — EBIT: -5026000.00
DRCT income_statement (quarterly, 2026-03-31) — EBITDA: -4532000.00
DRCT cash_flow (quarterly, 2026-03-31) — End Cash Position: 796000.00
DRCT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 1118000.00
DRCT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -1050000.00
DRCT income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 5513000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Goodwill: 6520000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 13958000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 3726000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1645000.00
DRCT income_statement (quarterly, 2026-03-31) — Gross Profit: 2262000.00
DRCT income_statement (quarterly, 2026-03-31) — Interest Expense: 545000.00
DRCT income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 545000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Interest Payable: 5000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 12127000.00
DRCT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 0.00
DRCT cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 1119000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Leases: 66000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 550000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 145000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 695000.00
DRCT cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 924000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Minority Interest: -5155000.00
DRCT income_statement (quarterly, 2026-03-31) — Minority Interests: 321000.00
DRCT cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 1119000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Net Debt: 15897000.00
DRCT income_statement (quarterly, 2026-03-31) — Net Income: -5250000.00
DRCT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -5932000.00
DRCT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -5571000.00
DRCT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -5250000.00
DRCT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -5250000.00
DRCT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -5571000.00
DRCT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -5571000.00
DRCT income_statement (quarterly, 2026-03-31) — Net Interest Income: -563000.00
DRCT cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1000.00
DRCT cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1000.00
DRCT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -563000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Net PPE: 788000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -18524000.00
DRCT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -2768000.00
DRCT income_statement (quarterly, 2026-03-31) — Normalized Income: -3486000.00
DRCT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -1050000.00
DRCT cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 517000.00
DRCT income_statement (quarterly, 2026-03-31) — Operating Income: -3251000.00
DRCT income_statement (quarterly, 2026-03-31) — Operating Revenue: 6680000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 700759.00
DRCT balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 826000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 16548000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 41000.00
DRCT income_statement (quarterly, 2026-03-31) — Other Gand A: 2492000.00
DRCT income_statement (quarterly, 2026-03-31) — Other Income Expense: -1757000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 7438000.00
DRCT cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1807000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 109000.00
DRCT income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 7000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Other Properties: 655000.00
DRCT income_statement (quarterly, 2026-03-31) — Other Special Charges: 1764000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Payables: 8806000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 10329000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 364000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
DRCT income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 682000.00
DRCT income_statement (quarterly, 2026-03-31) — Pretax Income: -5571000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
DRCT balance_sheet (quarterly, 2026-03-31) — Receivables: 2782000.00
DRCT income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 4418000.00
DRCT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 494000.00
DRCT cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -32970000.00
DRCT income_statement (quarterly, 2026-03-31) — Salaries And Wages: 3021000.00
DRCT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 5513000.00
DRCT balance_sheet (quarterly, 2026-03-31) — Share Issued: 700759.00
DRCT income_statement (quarterly, 2026-03-31) — Special Income Charges: -1764000.00